Copyright
©The Author(s) 2022.
World J Gastrointest Endosc. Nov 16, 2022; 14(11): 704-717
Published online Nov 16, 2022. doi: 10.4253/wjge.v14.i11.704
Published online Nov 16, 2022. doi: 10.4253/wjge.v14.i11.704
Table 1 Clinical and pathological features of patients with colorectal cancer according to decompression methods
Characteristic1 | All cases (n = 102) | Decompression methods | P value2 | |
Transanal tube (n = 76) | SEMS (n = 26) | |||
Sex, n (%) | 0.91 | |||
Female | 54 (53) | 40 (53) | 14 (54) | |
Male | 48 (47) | 36 (47) | 12 (46) | |
Age, mean ± SD (years) | 72.6 ± 12.5 | 71.7 ± 12.9 | 75.1 ± 11.1 | 0.24 |
Tumor location, n (%) | 0.24 | |||
Cecum to transverse colon | 16 (16) | 13 (17) | 3 (12) | |
Descending to sigmoid colon | 65 (64) | 45 (59) | 20 (77) | |
Rectum | 21 (21) | 18 (24) | 3 (12) | |
Tumor size, mean ± SD (mm) | 40.7 ± 16.2 | 39.0 ± 14.9 | 45.4 ± 19.3 | 0.086 |
Time from decompression to operation, mean ± SD (days) | 13.6 ± 12.9 | 12.0 ± 7.6 | 18.2 ± 21.7 | 0.035 |
Histological type, n (%) | 0.35 | |||
Well | 29 (28) | 19 (25) | 10 (38) | |
Moderate | 67 (66) | 53 (70) | 14 (54) | |
Mucinous, poor, or signet-ring cell | 6 (5.9) | 4 (5.3) | 2 (7.7) | |
T stage (depth of tumor invasion), n (%) | 0.57 | |||
T1 (submucosa) | - | - | - | |
T2 (muscularis propria) | 1 (1.0) | - | 1 (3.9) | |
T3 (subserosa) | 67 (66) | 54 (71) | 13 (50) | |
T4 (serosa or other organs) | 34 (33) | 22 (29) | 12 (46) | |
N stage (number of positive lymph nodes), n (%) | 0.54 | |||
N0 (0) | 49 (48) | 36 (47) | 13 (50) | |
N1 (1-3) | 39 (38) | 28 (37) | 11 (42) | |
N2 (4-) | 14 (14) | 12 (16) | 2 (7.7) | |
AJCC disease stage, n (%) | 0.40 | |||
I | 1 (1.0) | - | 1 (3.9) | |
II | 42 (41) | 31 (41) | 11 (42) | |
III | 36 (35) | 27 (36) | 9 (35) | |
IV | 23 (23) | 18 (24) | 5 (19) | |
Mutation status, n (%) | 0.51 | |||
KRAS mutated | 34 (43) | 26 (47) | 8 (33) | |
NRAS mutated | 3 (3.8) | 2 (3.6) | 1 (4.2) | |
BRAF mutated | 0 (0) | 0 (0) | 0 (0) | |
Absent | 42 (53) | 27 (49) | 15 (63) |
Table 2 Perioperative features of patients with colorectal cancer according to decompression methods
Characteristic1 | All cases (n = 102) | Decompression methods | P value2 | |
Transanal tube (n = 76) | SEMS (n = 26) | |||
Operation method, n (%) | 0.31 | |||
Open | 54 (53) | 38 (50) | 16 (62) | |
Laparoscopy | 48 (47) | 38 (50) | 10 (38) | |
Conversion to laparotomy, n (%) | 0.072 | |||
Absent | 47 (98) | 38 (100) | 9 (90) | |
Present | 1 (2.1) | - | 1 (10) | |
Procedure, n (%) | 0.17 | |||
Colectomy | 58 (57) | 44 (58) | 14 (54) | |
Anterior resection | 37 (36) | 25 (33) | 12 (46) | |
Hartmann procedure | 5 (4.9) | 5 (6.6) | - | |
Abdominoperineal resection (Miles’ operation) | 2 (2.0) | 2 (2.6) | - | |
Lymph node dissection, n (%) | 0.35 | |||
D1 | 3 (2.9) | 3 (4.0) | - | |
D2 | 10 (9.8) | 8 (11) | 2 (7.7) | |
D3 | 89 (87) | 65 (86) | 24 (92) | |
Reconstruction (except 2 abdominoperineal resection cases), n (%) | 0.011 | |||
Absent | 10 (10) | 10 (14) | - | |
Present | 90 (90) | 64 (86) | 26 (100) | |
Number of harvested lymph nodes, mean ± SD | 21.6 ± 12.0 | 21.5 ± 11.8 | 21.7 ± 12.6 | 0.97 |
Operation time, mean ± SD (min) | 241 ± 80 | 234 ± 79 | 263 ± 79 | 0.12 |
Blood loss, mean ± SD (g) | 224 ± 364 | 229 ± 375 | 212 ± 336 | 0.84 |
Clavien-Dindo classification, n (%) | 0.22 | |||
0 | 78 (76) | 58 (76) | 20 (77) | |
1 | 5 (4.9) | 5 (6.6) | - | |
2 | 11 (11) | 8 (11) | 3 (12) | |
3 | 7 (7.7) | 5 (6.6) | 2 (7.7) | |
4 | - | - | - | |
5 | 1 (1.0) | - | 1 (3.9) | |
Postoperative hospitalization, mean ± SD (days) | 18.8 ± 15.1 | 19.3 ± 17.0 | 17.2 ± 6.7 | 0.53 |
Postoperative chemotherapy, n (%) | 0.36 | |||
Absent | 51 (50) | 36 (47) | 15 (58) | |
Present | 51 (50) | 40 (53) | 11 (42) |
Table 3 Pathological features of patients with colorectal cancer according to decompression methods
Characteristic1 | All cases (n = 102) | Decompression methods | P value2,3 | |
Transanal tube (n = 76) | SEMS (n = 26) | |||
Lymphatic invasion, n (%) | 0.12 (0.020) | |||
Absent | 11 (11) | 10 (13) | 1 (3.9) | |
Minimal | 41 (40) | 33 (43) | 8 (31) | |
Moderate | 32 (31) | 23 (30) | 9 (35) | |
Severe | 18 (18) | 10 (13) | 8 (31) | |
Venous invasion, n (%) | < 0.0001 (0.0002) | |||
Absent | 19 (19) | 17 (22) | 2 (7.7) | |
Minimal | 45 (44) | 37 (49) | 8 (31) | |
Moderate | 23 (23) | 19 (25) | 4 (15) | |
Severe | 15 (15) | 3 (4.0) | 12 (46) |
Table 4 Pathological features of patients with colorectal cancer according to decompression methods in strata of American Joint Committee on Cancer-pT stage or tumor location
Characteristic1 | All cases (n = 102) | Decompression methods | P value2,3 | |
Transanal tube (n = 76) | SEMS (n = 26) | |||
Lymphatic invasion | ||||
AJCC-pT2/T3 cases, n (%) | 0.024 (0.036) | |||
Absent | 8 (12) | 8 (15) | - | |
Minimal | 31 (46) | 25 (46) | 6 (43) | |
Moderate | 20 (29) | 17 (31) | 3 (21) | |
Severe | 9 (13) | 4 (7.4) | 5 (36) | |
AJCC-pT4 cases, n (%) | 0.53 (0.56) | |||
Absent | 3 (8.8) | 2 (9.1) | 1 (8.3) | |
Minimal | 10 (29) | 8 (36) | 2 (17) | |
Moderate | 12 (35) | 6 (27) | 6 (50) | |
Severe | 9 (26) | 6 (27) | 3 (25) | |
Venous invasion | ||||
AJCC-pT2/T3 cases, n (%) | 0.0031 (0.0025) | |||
Absent | 13 (19) | 12 (22) | 1 (7.1) | |
Minimal | 37 (54) | 32 (59) | 5 (36) | |
Moderate | 12 (18) | 9 (17) | 3 (21) | |
Severe | 6 (8.8) | 1 (1.9) | 5 (36) | |
AJCC-pT4 cases, n (%) | 0.0077 (0.042) | |||
Absent | 6 (18) | 5 (23) | 1 (8.3) | |
Minimal | 8 (24) | 5 (23) | 3 (25) | |
Moderate | 11 (32) | 10 (45) | 1 (8.3) | |
Severe | 9 (26) | 2 (9.1) | 7 (58) | |
Lymphatic invasion | ||||
Cecum to transverse colon cases, n (%) | 0.21 (0.088) | |||
Absent | 3 (19) | 3 (23) | - | |
Minimal | 7 (44) | 6 (46) | 1 (33) | |
Moderate | 4 (25) | 4 (31) | - | |
Severe | 2 (13) | - | 2 (67) | |
Descending to rectum, n (%) | 0.40 (0.096) | |||
Absent | 8 (9.3) | 7 (11) | 1 (4.4) | |
Minimal | 34 (40) | 27 (43) | 7 (30) | |
Moderate | 28 (33) | 19 (30) | 9 (39) | |
Severe | 16 (19) | 10 (16) | 6 (26) | |
Venous invasion | ||||
Cecum to transverse colon cases, n (%) | 0.10 (0.078) | |||
Absent | 5 (31) | 5 (38) | - | |
Minimal | 6 (38) | 5 (38) | 1 (33) | |
Moderate | 2 (13) | 2 (15) | - | |
Severe | 3 (19) | 1 (7.7) | 2 (67) | |
Descending to rectum, n (%) | 0.0001 (0.0012) | |||
Absent | 14 (16) | 12 (19) | 2 (8.7) | |
Minimal | 39 (45) | 32 (51) | 7 (30) | |
Moderate | 21 (24) | 17 (27) | 4 (17) | |
Severe | 12 (14) | 2 (3.2) | 10 (43) |
Table 5 Logistic regression analyses to assess the association of decompression method (predictor) with severe venous invasion (outcome)
Model for severe venous invasion (n = 102, as a binary outcome variable) | Univariable | Multivariable1 | Multivariable2 | |||
OR (95%CI) | P value | OR (95%CI) | P value | OR (95%CI) | P value | |
Decompression methods | ||||||
Transanal tube | 1 (reference) | < 0.0001 | 1 (reference) | < 0.0001 | 1 (reference) | < 0.0001 |
SEMS | 20.9 (5.78-101) | 19.4 (5.24-96.2) | 36.7 (7.89-259) | |||
Age (for 10-yr increment) | 1.29 (0.82-2.20) | 0.28 | ||||
Sex | ||||||
Female | 1 (reference) | 0.60 | ||||
Male | 1.34 (0.44-4.14) | |||||
Tumor location | ||||||
Cecum to transverse colon | 1 (reference) | 0.27 | 1 (reference) | 0.27 | ||
Descending to sigmoid colon | 0.88 (0.23-4.31) | 0.38 (0.05-2.60) | ||||
Rectum | 0.22 (0.01-1.90) | 0.11 (0.003-1.58) | ||||
Waiting period (for 1-wk increment) | 0.91 (0.47-1.22) | 0.64 | ||||
Tumor size (for 10-mm increment) | 1.10 (0.78-1.49) | 0.55 | ||||
Histological type | ||||||
Well | 1 (reference) | 0.21 | 1 (reference) | 0.065 | ||
Moderate | 2.65 (0.65-17.9) | 7.27 (1.27-64.5) | ||||
Mucinous, poor, or signet-ring cell | 6.75 (0.66-72.0) | 10.7 (0.48-342) | ||||
AJCC-pT | ||||||
T2/T3 | 1 (reference) | 0.021 | 1 (reference) | 0.084 | 1 (reference) | 0.082 |
T4 | 3.72 (1.22-12.2) | 3.17 (0.86-12.6) | 3.76 (0.85-19.4) | |||
Mutation | ||||||
Absent | 1 (reference) | 0.81 | ||||
Present (KRAS, NRAS) | 1.16 (0.33-4.07) |
Table 6 Pathological features of patients with colorectal cancer according to decompression methods (transanal tube vs 18-mm stent vs 22-mm stent)
Characteristic1 | All cases (n = 102) | Decompression methods | P value2,3 | ||
Transanal tube (n = 76) | 18 mm stent (n = 11) | 22 mm stent (n = 15) | |||
Lymphatic invasion, n (%) | 0.055 (0.0060) | ||||
Absent | 11 (11) | 10 (13) | 1 (9.1) | - | |
Minimal | 41 (40) | 33 (43) | 5 (45) | 3 (20) | |
Moderate | 32 (31) | 23 (30) | 4 (36) | 5 (33) | |
Severe | 18 (18) | 10 (13) | 1 (9.1) | 7 (47) | |
Venous invasion, n (%) | < 0.0001 (0.0006) | ||||
Absent | 19 (19) | 17 (22) | 2 (18) | - | |
Minimal | 45 (44) | 37 (49) | 3 (27) | 5 (33) | |
Moderate | 23 (23) | 19 (25) | 1 (9.1) | 3 (20) | |
Severe | 15 (15) | 3(4.0) | 5 (45) | 7 (47) |
- Citation: Kosumi K, Mima K, Kanemitsu K, Tajiri T, Takematsu T, Sakamoto Y, Inoue M, Miyamoto Y, Mizumoto T, Kubota T, Miyanari N, Baba H. Self-expanding metal stent placement and pathological alterations among obstructive colorectal cancer cases. World J Gastrointest Endosc 2022; 14(11): 704-717
- URL: https://www.wjgnet.com/1948-5190/full/v14/i11/704.htm
- DOI: https://dx.doi.org/10.4253/wjge.v14.i11.704